Clinical Implications of Genetic Testing in Hypertrophic Cardiomyopathy

American Heart Association
8/11/20, 4:00 PM
America/Chicago UTC -5

Description

Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age. It is estimated that 1 in every 500 people in the U.S. have HCM, but a large percentage of patients are undiagnosed. Which of your patients is undiagnosed?

 

The goal of this webinar is to offer a historical perspective and current state of HCM genetics. Additionally, subject matter experts discuss topics such as relevant terminology, determining who to test and the interpretations of those tests, and identifying HCM phenocopies, with the goal of improving patient outcomes.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Clinical Implications of Genetic Testing in Hypertrophic Cardiomyopathy

Inglês

 

Speakers

James E. Udelson, Sharon Cresci, Robert Fraser, Anjali Tiku Owens, Stephanie Turrise, Ahmet Kilic

 

Link to the Event

Banner to the Event

Clinical Implications of Genetic Testing in Hypertrophic Cardiomyopathy